VIR VIR BIOTECHNOLOGY INC
2026Q1 · CUSIP 92764N102 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
251
Δ holders QoQ
+33
Breadth percentile
Top 8%
Whale holders
131
Δ whales
+12
Inst. holding value
$1.2B
New positions
70
Closed positions
37
Price momentum (1Q)
+16.9%
Put / Call
5/7
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 8% | — | — |
| 2025Q1 | Top 9% | -6.0% | +18.3% |
| 2022Q3 | Top 12% | -5.7% | -7.2% |
| 2022Q2 | Top 15% | +0.4% | -0.1% |
| 2021Q4 | Top 15% | -31.0% | -24.4% |
| 2021Q3 | Top 18% | -1.5% | -32.0% |
| 2020Q2 | Top 5% | -49.7% | +49.3% |
| 2020Q1 | Top 3% | +33.7% | -32.7% |
Options Sentiment
Put holders
5
QoQ: +3
Call holders
7
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.13
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+214.0%
Net margin
—
ROE
-54.5%
Debt ratio
20.8%
FCF (TTM)
-$450M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.